SNN - Smith & Nephew plc
35.42 -0.01 (-0.01%)
After hours: 4:02PM EDT
| Previous Close | 35.30 |
| Open | 35.38 |
| Bid | 33.66 x 1300 |
| Ask | 37.31 x 800 |
| Day's Range | 35.25 - 35.50 |
| 52 Week Range | 33.79 - 40.43 |
| Volume | 234,637 |
| Avg. Volume | 544,085 |
| Market Cap | 15.995B |
| Beta | 0.25 |
| PE Ratio (TTM) | 20.19 |
| EPS (TTM) | 1.75 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.70 (1.95%) |
| Ex-Dividend Date | 2018-04-05 |
| 1y Target Est | 40.57 |
- Benzinga•3 days ago
AxisWire: Cannabis Companies Are Moving To Canada, Its Friendlier Legal Climate
Canada possesses more short-term advantages for going public, as cannabis business owners benefit from operating in a market that carries little legal risk. “Sure, nine states have legalized recreational cannabis, but it’s still federally illegal. Canadian company Sunniva, Inc. (CNSX: SNN) plans to obtain licensing in both Canada and California, making it one of the first cannabis companies operating in both regions.
- Reuters•20 days ago
Smith & Nephew buoyed by recovery in U.S. market
Smith & Nephew's new chief executive confirmed the company's full-year guidance on Thursday after improvement in its U.S. market helped revenues for the artificial hip and knee maker to recover from a tough start to the year. Smith & Nephew (SN.L) said underlying revenue growth for the year was still expected to be 2-3 percent, after it cut its outlook in its previous trading statement in May, one of the last acts of its previous CEO. New boss Namal Nawana said that while Europe remained soft, there had been improvement in the United States, where the company derives about half of its revenues.
- PR Newswire•20 days ago
JOURNEY™ II BCS Knee System demonstrates improved patient outcomes and lower healthcare costs
LONDON , July 25, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announced positive clinical results concerning its JOURNEY™ II Bi-Cruciate Stabilized ...
- ACCESSWIRE•25 days ago
Today’s Free Research Reports Coverage on Neovasc and Three More Healthcare Stocks
Under assessment this morning are these four equities: Myomo Inc. (NYSE AMER: MYO), Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), and Insulet Corp. (NASDAQ: PODD). All you have to do is sign up today for this free limited time offer by clicking the link below.
- PR Newswire•last month
UK’s NICE Publishes a Medtech Innovation Briefing on PICO™ for the Prophylactic Use in Surgically Closed Incisions to Reduce Surgical Site Complications
LONDON and NEW YORK , July 3, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN) (NYSE: SNN), the global medical technology business, announces that the UK's National Institute for Health and Care Excellence ...
- ACCESSWIRE•2 months ago
Neovasc and Three Additional Medical Appliances & Equipment Stocks on Our Research Desk’s Radar
This Monday, WallStEquities.com has initiated reports coverage on the following Medical Appliances & Equipment equities: Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), Accuray Inc. (NASDAQ: ARAY), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). All you have to do is sign up today for this free limited time offer by clicking the link below.
- Simply Wall St.•2 months ago
Is Smith & Nephew plc’s (LON:SN.) Balance Sheet Strong Enough To Weather A Storm?
The size of Smith & Nephew plc (LSE:SN.), a UK£11.91B large-cap, often attracts investors seeking a reliable investment in the stock market. Big corporations are much sought after by risk-averseRead More...
- Reuters•3 months ago
Outgoing Smith & Nephew CEO signs off with a downgrade
Smith & Nephew downgraded its revenue and profit forecasts after a weak first quarter on Thursday, days before Chief Executive Olivier Bohuon will end his seven-year tenure at the artificial knee and hip maker. It also lowered trading profit forecasts, predicting a margin at or above the level achieved last year rather than the 30-70 basis point growth it had targeted. Bohuon, who steps down on Monday, said the business had seen a "mixed performance" in the quarter to end-March, with established markets like the United States and Europe down 2 percent on an underlying basis and emerging markets up 9 percent, resulting in a flat result overall.
- Simply Wall St.•4 months ago
Does Smith & Nephew plc’s (LON:SN.) PE Ratio Warrant A Buy?
Smith & Nephew plc (LSE:SN.) trades with a trailing P/E of 21.7x, which is lower than the industry average of 29.6x. While this makes SN. appear like a great stockRead More...
- Simply Wall St.•4 months ago
Smith & Nephew plc (LON:SN.) Delivered A Better ROE Than The Industry, Here’s Why
Smith & Nephew plc (LSE:SN.) delivered an ROE of 16.52% over the past 12 months, which is an impressive feat relative to its industry average of 10.23% during the sameRead More...
- American City Business Journals•4 months ago
Former Alere CEO named to head another medical device giant
One of Massachusetts’ largest medical device employers, London-based Smith & Nephew, has named a new CEO who’ll be familiar to that company’s 1,100 Massachusetts employees.
- Reuters•4 months ago
Smith & Nephew picks new CEO who sold his last company
Artificial hip and knee maker Smith & Nephew (SN.L), a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making. Namal Nawana, who will replace Olivier Bohuon as CEO of the British company next month, most recently headed medical diagnostics firm Alere, where he oversaw its $5.3 billion sale to Abbott (ABT.N) in 2017. The medical technology firm, which also has wound-care and sports medicine units, is under pressure to improve margins and find new sources of growth as it competes with bigger rivals.
- Zacks•5 months ago
Smith & Nephew (SNN): Moving Average Crossover Alert
Smith & Nephew plc (SNN) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
- American City Business Journals•5 months ago
Manufacturing company adding 100 jobs in Fort Worth in $29M expansion
Medical equipment supplier Smith & Nephew Inc. has selected its Fort Worth facility to locate a $29 million project, creating 100 new jobs. Fort Worth beat out at least three other cities for the project.
- PR Newswire•5 months ago
Smith & Nephew Supports AAFAO Courses with Donation of More Than $3M of Equipment to The Podiatry Institute
LSE:SN), the global medical technology business, today announces the donation of more than $3M of trauma plates and screws, external fixation implants and instruments to The Podiatry Institute (PI). This equipment will be used to support ongoing educational courses conducted at the PI through the American Academy of Foot and Ankle Osteosynthesis (AAFAO). Smith & Nephew has been the sole sponsor of the comprehensive and advanced educational courses conducted by the PI and AAFAO for the past four years, contributing to resident education for nearly 1600 participants.
- Simply Wall St.•5 months ago
Does Smith & Nephew plc’s (LON:SN.) -2.17% Earnings Drop Reflect A Longer Term Trend?
Measuring Smith & Nephew plc’s (LSE:SN.) track record of past performance is an insightful exercise for investors. It enables us to reflect on whether the company has met or exceedRead More...
- PR Newswire•5 months ago
IIROC Trade Resumption - SNN
VANCOUVER , March 7, 2018 /CNW/ - Trading resumes in: Company: Sunniva Inc. CSE Symbol: SNN Resumption (ET): 9:30 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security ...
